A Quick Look At AstraZeneca Plc’s Cash Flow Statement

A whistle-stop tour of AstraZeneca plc (LON:AZN)’s financial notes.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In this series of articles looking at financial statements, we are going to see if we can delve into AstraZeneca  (LSE: AZN) (NYSE: AZN.US)’s cash flow statement for the year ended 31 December 2012.  If you are new to investing, or are just baffled by some of the terms that make up a cash flow statement, then read on.

Again, I will start by noting the cash flow statement is only one of three main financial statements. Both the balance sheet and income statement are as important, and should be viewed in conjunction to gain the full picture.

The cash flow statement is very useful in gaining a real understanding of what has actually happened during the year.  Unlike the income statement, which is ruled by accrual accounting, and the balance sheet, which is a mere snapshot of one point in time, the cash flow statement gives a perspective on how AstraZeneca has performed in hard cash.  There are far less hiding places to be had when reporting this one.

Cash is king

The format is always the same with cash flow statements.  Cash from operating activities come first, then investing activities and finally financing activities.  ‘Operating activities’ shows the performance during the year which in AstraZeneca’s case is a disappointing fall of 25% to $9.5bn before interest and tax.  The main driver is the profit fall rather than any particular cash movement considerations, though.

Raid the savings to boost that pipeline

‘Investing activities’ includes two lines of note.  The movement of short-term investments and fixed deposits produced a cash inflow of $3.6bn.  Note 10 reveals that fixed deposits were realised to the value of $3.9bn with a mere $46m remaining.  A significant reduction in that investment base.  Contrary to this, the purchase of intangible assets led to a cash outflow of $3.9bn.  Note 9 gives us the detail concerning the diabetes alliance  collaboration with BMS amounting to $3.7bn.

Finally, in financing activities, we can see quite a bit of action with $3.7bn paid out in dividends and a further $2.6bn for the repurchase of shares.  The repayment of existing loans was offset by the uptake of new loans, both just under $2bn.  The overall cash inflow after everything has been taken into account is just $166m.  The dividends are at least covered almost 2 times by cash inflow from operating activities after tax and there is still a healthy $7.6bn balance at the end of the year.

Hopefully that whistle-stop tour was helpful although, as ever, there are many more terms that could be cleared up as well.

If you found this introduction to balance sheets useful, there are more investing hints and tips in this completely free report. Why not take a look to see if you can get one step ahead of the herd?

If you are feeling more adventurous, try 10 Steps To Making A Million In The Market, which can set you on the right path on your investing journey.

Both reports are completely free and can help you avoid the common novice investor mistakes.

> Barry owns shares in AstraZeneca.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Company Comment

Hand of person putting wood cube block with word VALUE on wooden table
Company Comment

Value has been building behind the Diageo share price

Despite the business growing, the Diageo share price first reached its current level just over 19 months ago and hasn't…

Read more »

Older couple walking in park
Investing Articles

5 stocks to buy for high and rising dividend income

I can see a host of shares to buy on the FTSE 100 offering me exceptional levels of income. Here…

Read more »

Young mixed-race woman looking out of the window with a look of consternation on her face
Investing Articles

I don’t care if FTSE 100 shares fall further, I’m buying them today

I'm happy to go shopping for FTSE 100 shares today, even though I accept that they could have further to…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

Rolls-Royce shares are down 18% in a month and I’m finally going to buy them

Investors who bought Rolls-Royce shares have been repeatedly disappointed, but I'm willing to take a chance on them before they…

Read more »

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

How I’d invest £10k in a Stocks and Shares ISA today

Now looks like a good time to buy cheap FTSE 100 shares inside a Stocks and Shares ISA. These are…

Read more »

Black father holding daughter in a field of cows
Investing Articles

Today’s financial crisis is the perfect moment to buy cheap shares

I'm building a portfolio of FTSE 100 stocks by purchasing cheap shares whenever I see an opportunity. There's a good…

Read more »

Long-term vs short-term investing concept on a staircase
Investing Articles

I’d buy Tesco shares in October to bag their 5.4% yield 

Tesco shares have fallen lately but I think this makes them attractively valued for a dividend stock I would aim…

Read more »

Young mixed-race woman looking out of the window with a look of consternation on her face
Investing Articles

I would do anything to hold Diageo in my portfolio (but I won’t do that)

Diageo is one of my favourite stocks on the entire FTSE 100 and I'd love to hold it, but one…

Read more »